Cargando…

RUNX2 Reverses p53-Induced Chemotherapy Resistance in Gastric Cancer

OBJECTIVE: Gastric cancer is one of the most common malignancies worldwide; however, its overall mortality has not improved significantly over the last decade. Chemoresistance plays a critical role in this issue. This study aimed to clarify the role and mechanism of runt-related transcription factor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yuan, Liang, Lu, Zhao, Yong-Xiang, Yao, Bi-Hui, Zhang, Rui-Min, Song, Lei, Zhang, Zhong-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065424/ https://www.ncbi.nlm.nih.gov/pubmed/37009416 http://dx.doi.org/10.2147/PGPM.S394393

Ejemplares similares

Functional relationship between p53 and RUNX proteins
por: Bae, Suk-Chul, et al.
Publicado: (2018)

p53 Deficiency-Dependent Oncogenicity of Runx3
por: Ito, Kosei, et al.
Publicado: (2023)

Methylation and expression of RECK, P53 and RUNX genes in patients with esophageal cancer
por: Lu, Yanrong, et al.
Publicado: (2017)

Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
por: Ozaki, Toshinori, et al.
Publicado: (2018)

RUNX Family Participates in the Regulation of p53-Dependent DNA Damage Response
por: Ozaki, Toshinori, et al.
Publicado: (2013)

Runt‐related transcription factor 1 (Runx1) aggravates pathological cardiac hypertrophy by promoting p53 expression
por: Zhang, Dianhong, et al.
Publicado: (2021)

Oncogenic RUNX3: A Link between p53 Deficiency and MYC Dysregulation
por: Date, Yuki, et al.
Publicado: (2020)

Identification of the hub genes RUNX2 and FN1 in gastric cancer
por: Han, Chao, et al.
Publicado: (2020)

TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell
por: Lei, Guoqiong, et al.
Publicado: (2021)

The role of p53 in cancer drug resistance and targeted chemotherapy
por: Hientz, Karin, et al.
Publicado: (2016)

Triangular Relationship between p53, Autophagy, and Chemotherapy Resistance
por: Xu, Jingwen, et al.
Publicado: (2020)

circLARP4 induces cellular senescence through regulating miR‐761/RUNX3/p53/p21 signaling in hepatocellular carcinoma
por: Chen, Zhiqiang, et al.
Publicado: (2019)

A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells
por: Shin, Min Hwa, et al.
Publicado: (2016)

Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells
por: Morita, Ken, et al.
Publicado: (2017)

Relationship between P53 Status and Response to Chemotherapy in Patients with Gastric Cancer: A Meta-Analysis
por: Xu, Hai-Yuan, et al.
Publicado: (2014)

Addiction to Runx1 is partially attenuated by loss of p53 in the Eμ-Myc lymphoma model
por: Borland, Gillian, et al.
Publicado: (2016)

The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN
por: Ando, Kiyohiro, et al.
Publicado: (2023)

Association between RUNX3 promoter methylation and gastric cancer: a meta-analysis
por: Fan, Xiao-yuan, et al.
Publicado: (2011)

Expression and biological function of rhotekin in gastric cancer through regulating p53 pathway
por: Sun, Meng-Yao, et al.
Publicado: (2019)

Collaboration of MYC and RUNX2 in lymphoma simulates T‐cell receptor signaling and attenuates p53 pathway activity
por: Hay, Jodie, et al.
Publicado: (2019)

Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2
por: Ozaki, Toshinori, et al.
Publicado: (2015)

p53-Induced Autophagy Regulates Chemotherapy and Radiotherapy Resistance in Multidrug Resistance Cancer Cells
por: Ma, Shumei, et al.
Publicado: (2021)

P53 mutations in gastric carcinomas.
por: Seruca, R., et al.
Publicado: (1992)

Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis
por: Roos, Alison, et al.
Publicado: (2015)

miR-215 promotes malignant progression of gastric cancer by targeting RUNX1
por: Li, Na, et al.
Publicado: (2015)

Functional interplay between p63 and p53 controls RUNX1 function in the transition from proliferation to differentiation in human keratinocytes
por: Masse, I, et al.
Publicado: (2012)

Chitosan‐Gelatin‐EGCG Nanoparticle‐Meditated LncRNA TMEM44‐AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5‐FU Resistance in Gastric Cancer
por: Zhou, Mi, et al.
Publicado: (2022)

Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma
por: Peng, Jian-Heng, et al.
Publicado: (2019)

miRNA‐532‐5p functions as an oncogenic microRNA in human gastric cancer by directly targeting RUNX3
por: Xu, Xia, et al.
Publicado: (2015)

p53 protein overexpression and allele loss of p53 gene in gastric adenocarcinoma.
por: Choi, S. W., et al.
Publicado: (1994)

p53 Genetic Polymorphism of Gastric cancer in Korea
por: Chung, Woo Chul, et al.
Publicado: (2006)

CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis
por: Lai, Qiuhua, et al.
Publicado: (2020)

Reversal of Chemotherapy Resistance to Cisplatin in NSCLC by miRNA-195-5p via Targeting the FGF2 Gene
por: Wang, Hao, et al.
Publicado: (2021)

Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals
por: Zhou, Pengjun, et al.
Publicado: (2017)

Role of p53 in the progression of gastric cancer
por: Busuttil, Rita A., et al.
Publicado: (2014)

HBXIP Regulates Gastric Cancer Glucose Metabolism and Malignancy Through PI3K/AKT and p53 Signaling
por: Qiu, Lei, et al.
Publicado: (2020)

Two Novel C-Terminus RUNX2 Mutations in Two Cleidocranial Dysplasia (CCD) Patients Impairing p53 Expression
por: Dalle Carbonare, Luca, et al.
Publicado: (2021)

Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63
por: Ogata, Takehiro, et al.
Publicado: (2017)

Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals
por: Xie, Hongjun, et al.
Publicado: (2015)

The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis
por: Guo, Zhengjun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9rskr7bfm5vvb99qlkjdd6625s